Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Lin YangXiangyuan Liu

Abstract

The muscarinic type 3 receptor (M3R) plays a pivotal role in the pathogenesis of Sjögren's syndrome (SS). Characterization of the crosstalk between M3R and EGFR has been investigated in some human malignancies. In the current study, we sought to investigate whether EGFR mimic immunization could alleviate the abnormal immune responses in an experimental SS-like model triggered by M3R peptides. After immunization with the combination of mimotope and M3R peptide, the active immunization targeting EGFR induced by the mimotope could reduce the marked infiltration of mononuclear cells, the high titer of antibodies against M3R and the accumulation of crucial pro-inflammatory cytokines in mice immunized with M3R peptide. Mechanistic analysis showed that mimotope immunization could alleviate the autoimmune response through inhibiting mitochondrion-mediated anti-apoptosis and up-regulating the FAS apoptosis pathway. These results may help to clarify the role of M3R in the pathogenesis of SS and suggested that transactivation of the EGFR signaling pathway may help M3R activate the autoimmune response in the pathogenesis of SS.

References

Feb 1, 1974·Oral Surgery, Oral Medicine, and Oral Pathology·J S GreenspanR A Sylvester
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·S J UllrichE Appella
Jan 1, 1996·Critical Reviews in Neurobiology·J Wess
Jan 31, 1998·The EMBO Journal·H DaubA Ullrich
Nov 1, 2000·Cell·J Schlessinger
Jul 17, 2004·Cancer Research·Damian B S YapXin Lu
Mar 15, 2006·The British Journal of Ophthalmology·A HiguchiK Tsubota
Sep 1, 2007·Nature Reviews. Drug Discovery·Jürgen WessDinesh Gautam
Sep 11, 2007·Immunology Letters·Angelika B Riemer, Erika Jensen-Jarolim
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Liqin BanDenise L Faustman
Jan 27, 2009·Critical Reviews in Immunology·Jeremy P McAleer, Anthony T Vella
Jun 4, 2010·European Journal of Pharmacology·Jeffrey M Greenwood, Michael Dragunow
Jun 15, 2010·Cancer Immunology, Immunotherapy : CII·Lin YangZonghai Li
Jul 27, 2011·Biochemical Pharmacology·Stéphane PierreXavier Coumoul
Dec 14, 2011·Investigative Ophthalmology & Visual Science·Xinye XiaoZuguo Liu
Oct 16, 2014·British Journal of Haematology·Gaetane Nocturne, Xavier Mariette

❮ Previous
Next ❯

Citations

Aug 15, 2018·International Journal of Molecular Sciences·Hideki NakamuraAtsushi Kawakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis